Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment

Critical Care Medicine

Volumn 25, Issue 7, 1997, Pages 1095-1100

  Zeni, F ^a   Freeman, B ^a   Natanson, C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Anti inflammatory agents; Clinical trials; Interleukin 1 receptor antagonist; Sepsis; Septic shock

Indexed keywords

BETAMETHASONE; BRADYKININ ANTAGONIST; CB 006; DELTIBANT; DEXAMETHASONE; GINKGOLIDE B; GLUCOCORTICOID; HYDROCORTISONE; IBUPROFEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MAK 195F; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; P 55; P 80; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; DRUG RESEARCH; DRUG SCREENING; EDITORIAL; HUMAN; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; TREATMENT PLANNING;

ANTI-INFLAMMATORY AGENTS; CLINICAL TRIALS; GLUCOCORTICOIDS; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; RECEPTORS, IMMUNOLOGIC; RECEPTORS, INTERLEUKIN-1; RECOMBINANT PROTEINS; SEPSIS; SHOCK, SEPTIC; SIALOGLYCOPROTEINS;

EID: 0030746482     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199707000-00001     Document Type: Editorial

References (38)